Divergent and conflicting recommendations regarding the initiation and frequency of colorectal, breast, and prostate cancer screening leave many individuals unsure about whether, when, and how often to undergo colonoscopy, screening mammography, or PSA testing. This evidence concerns the gene KLK3 and prostate cancer.